What is the Market Cap of
GLAND PHARMA ?


The Current Market Cap of GLAND PHARMA is ₹50,535.5 Cr.

Current Share Price: ₹3,070.2
Updated EOD on : May 20,2022.

COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results
GLAND PHARMA is part of below Screeners ↓
Best Quarterly Growth Large Cap Stocks

Change in Market Cap of GLAND PHARMA

Market Cap Change(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.3%

-6.3%

1%

SENSEX

2.9%

-3.8%

9.6%


Peer Comparison with Market Cap of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹50,535.5 Cr -1.3% -6.3% 1% FULL ANALYTICS
ABBOTT INDIA ₹38,190.1 Cr 8.7% 6.6% 13.1% FULL ANALYTICS
ALKEM LABORATORIES ₹35,885.0 Cr 3.4% -11.9% -1.1% FULL ANALYTICS
AUROBINDO PHARMA ₹32,686.6 Cr 1.3% -16.8% -48% FULL ANALYTICS
AJANTA PHARMA ₹14,805.7 Cr 3% -1.7% -10.6% FULL ANALYTICS
ALEMBIC PHARMACEUTICALS ₹14,798.2 Cr 1.8% -0.7% -22.1% FULL ANALYTICS
ASTRAZENECA PHARMA INDIA ₹6,406.8 Cr 2.9% -6% -33% FULL ANALYTICS
AARTI DRUGS ₹3,889.2 Cr 0.3% -13.1% -45.4% FULL ANALYTICS
ADVANCED ENZYME TECHNOLOGIES ₹3,107.7 Cr 1.7% -11.7% -39.8% FULL ANALYTICS
AMRUTANJAN HEALTH CARE ₹2,441.3 Cr 1.1% -6.1% 16.9% FULL ANALYTICS
ALEMBIC ₹1,797.5 Cr 2.5% -13% -42.5% FULL ANALYTICS
BAJAJ HEALTHCARE ₹897.1 Cr 6.9% -5.5% 8.3% FULL ANALYTICS
ANUH PHARMA ₹496.6 Cr 4.2% -1.3% -36.1% FULL ANALYTICS
ALBERT DAVID ₹307.6 Cr 1.9% -9.9% 21.1% FULL ANALYTICS
BAFNA PHARMACEUTICALS ₹298.1 Cr -0.8% -3.2% -8.1% FULL ANALYTICS
AMBALAL SARABHAI ENTERPRISES ₹239.9 Cr 1.3% -11% -34.8% FULL ANALYTICS
BAL PHARMA ₹160.2 Cr 1% -8.3% 11% FULL ANALYTICS
ALPA LABORATORIES ₹147.2 Cr 4.1% -12.1% 18.3% FULL ANALYTICS
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ₹127.4 Cr 3.7% -10.5% -50.4% FULL ANALYTICS
BDH INDUSTRIES ₹71.1 Cr 0.5% -13.3% 21.5% FULL ANALYTICS
AURO LABORATORIES ₹59.7 Cr 1.5% -11.6% -9.6% FULL ANALYTICS

GLAND PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 3.7% -8.4% 12.6%
S&P BSE ALLCAP 3.2% -5.8% 10.3%
S&P BSE MID CAP 3.2% -8% 8%
S&P BSE 500 3.2% -5.6% 9.7%
S&P BSE LARGE MIDCAP 3.1% -5.2% 9.2%
S&P BSE 250 LARGEMIDCAP 3.1% -5.3% 9.5%
S&P BSE 200 3.1% -5.2% 9.3%
S&P BSE 100 LARGECAP TMC 3% -4.9% 9.1%
S&P BSE HEALTHCARE 2.8% -6.4% -4.8%
NSE Indices1W1M1Y
NIFTY PHARMA 3.5% -3.4% -5.7%
NIFTY500 MULTICAP 50:25:25 3.4% -6.8% 11%
NIFTY MNC 3.3% -2.6% 8%
NIFTY 500 3.1% -5.7% 9.7%
NIFTY 100 3.1% -4.9% 8.9%
NIFTY 200 3% -5.3% 9.3%
NIFTY LARGE MIDCAP 250 3% -6% 10.5%
NIFTY 100 EQUAL WEIGHT 2.9% -7% 6.9%
NIFTY NEXT 50 2.8% -9.3% 6.4%
NIFTY 100 ALPHA 30 0.2% -15.1% 10.3%

You may also like the below Video Courses



SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z